News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
679,048 Results
Type
Article (38781)
Company Profile (247)
Press Release (640020)
Section
Business (203519)
Career Advice (1977)
Deals (35345)
Drug Delivery (78)
Drug Development (80612)
Employer Resources (167)
FDA (16015)
Job Trends (14778)
News (343698)
Policy (32406)
Tag
Academia (2528)
Africa (711)
Alliances (48973)
Alzheimer's disease (1145)
Approvals (15939)
Arizona (174)
Artificial intelligence (69)
Asia (36802)
Australia (5984)
Bankruptcy (350)
Best Places to Work (11281)
Biosimilars (63)
Biotechnology (176)
C2C Services and Suppliers (78791)
California (1872)
Canada (931)
Cancer (488)
Career advice (1647)
Cell therapy (120)
China (150)
Clinical research (63211)
Collaboration (139)
Colorado (77)
Compensation (81)
Connecticut (74)
COVID-19 (2486)
Cystic fibrosis (73)
Data (312)
Diabetes (81)
Diagnostics (5972)
Drug pricing (63)
Earnings (83646)
Employer resources (142)
Europe (78619)
Events (107804)
Executive appointments (151)
FDA (16243)
Florida (264)
Funding (148)
Gene therapy (92)
GLP-1 (510)
Government (4290)
Healthcare (18612)
Hotbed/Location (480947)
Illinois (254)
Indiana (146)
Infectious disease (2513)
Inflammatory bowel disease (91)
Interviews (305)
IPO (16201)
Job creations (3618)
Job search strategy (1412)
Kansas (94)
Layoffs (393)
Legal (7830)
Lung cancer (110)
Manufacturing (86)
Maryland (395)
Massachusetts (1522)
Medical device (13046)
Medtech (13051)
Mergers & acquisitions (19014)
Metabolic disorders (247)
Michigan (124)
Minnesota (214)
Neuroscience (1290)
New Jersey (578)
New York (592)
NextGen Class of 2024 (6479)
Non-profit (4457)
North Carolina (588)
Northern California (822)
Obesity (146)
Ohio (104)
Opinion (171)
Patents (71)
Pennsylvania (580)
People (55838)
Pharmaceutical (60)
Phase I (19581)
Phase II (27840)
Phase III (20803)
Pipeline (112)
Postmarket research (2546)
Preclinical (8317)
Press Release (64)
Rare diseases (130)
Real estate (5882)
Recruiting (63)
Regulatory (21196)
Research institute (2304)
Resumes & cover letters (346)
South America (1085)
Southern California (759)
Startups (3559)
Texas (239)
United States (8533)
Vaccines (472)
Washington State (253)
Weight loss (127)
Date
Today (101)
Last 7 days (692)
Last 30 days (2428)
Last 365 days (37134)
2024 (26150)
2023 (40074)
2022 (51173)
2021 (55713)
2020 (54087)
2019 (46541)
2018 (35019)
2017 (32111)
2016 (31480)
2015 (37552)
2014 (31319)
2013 (26346)
2012 (28570)
2011 (29263)
2010 (27328)
679,048 Results for "caredx inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Biotech Bay
CareDx to Participate in Upcoming Investor Conferences - May 29, 2024
CareDx, Inc. today announced that the Company will participate in two upcoming investor conferences.
May 29, 2024
·
1 min read
Business
CareDx Reports First Quarter 2024 Results
CareDx, Inc. – reported financial results for the first quarter ended March 31, 2024.
May 9, 2024
·
13 min read
Biotech Bay
Landmark Study Shows CareDx’s HeartCare Outperforms dd-cfDNA Alone in Identifying Rejection and Patients Experienced Excellent Outcomes with Fewer Biopsies
CareDx, Inc. announced findings from the SHORE study, one of the largest heart transplant studies of its kind, published in The Journal of Heart and Lung Transplantation.
May 16, 2024
·
5 min read
Biotech Bay
AI Integration and Real-World Utility of CareDx Portfolio Highlighted in New Data at the 2024 American Transplant Congress
CareDx, Inc. announced new data to be presented at the 2024 American Transplant Congress being held June 1-5 in Philadelphia.
May 30, 2024
·
6 min read
Business
CareDx Appoints Bryan Riggsbee to Its Board of Directors - March 11, 2024
CareDx, Inc. announced that Bryan Riggsbee joins CareDx’s Board of Directors, effective March 11, 2024.
March 11, 2024
·
3 min read
Biotech Bay
CareDx Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - May 03, 2024
CareDx, Inc. announced that, as an inducement material to entering into employment with CareDx, on April 19, 2024, 17 new employees were awarded restricted stock units for an aggregate of 54,350 shares of common stock.
May 3, 2024
·
3 min read
Biotech Bay
CareDx and Collaborators Present Latest Cardiothoracic Advancements at the 2024 International Society for Heart and Lung Transplantation Meeting
CareDx, Inc. today announced that CareDx and study collaborators will be presenting the latest data featuring CareDx’s cardiothoracic portfolio at the International Society for Heart and Lung Transplantation (ISHLT) 44th Annual Meeting & Scientific Sessions, taking place from April 10-13 in Prague, Czech Republic.
April 9, 2024
·
5 min read
Business
CareDx to Report First Quarter 2024 Financial Results
CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers – today announced it will report financial results for the first quarter 2024 after market close on Thursday, May 9, 2024.
April 29, 2024
·
1 min read
Business
CareDx Appoints John W. Hanna as its New President and Chief Executive Officer
CareDx, Inc. has appointed John W. Hanna as its new President and Chief Executive Officer, and member of the Company’s Board of Directors, effective April 15, 2024.
April 16, 2024
·
3 min read
Biotech Bay
Landmark Independent Publication in Nature Medicine Validates CareDx AlloView AI-Enabled Risk Prediction Model and Demonstrates AlloSure Kidney Detects Subclinical Rejection in Stable Patients
CareDx, Inc. announced in conjunction with the 2024 American Transplant Congress, the publication in Nature Medicine of findings from the largest, real-world study of its kind, assessing the role of AlloSure® donor-derived cell-free DNA and of an AI-enabled rejection risk prediction model, AlloView™ that incorporates AlloSure to improve detection, characterization, and treatment of kidney allograft rejection.
June 3, 2024
·
5 min read
1 of 67,905
Next
